Suchergebnisse - "Vertosick, Emily"

PubPharm (6)

1

Value of Partial Nephrectomy for Renal Cortical Tumors of cT2 or Greater Stage : A Risk-benefit Analysis of Renal Function Preservation Versus Increased Postoperative Morbidity

enthalten in: European urology oncology | 2020

von Vilaseca, A. | Guglielmetti, G. | Vertosick, E. | +9

2

A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts

enthalten in: European urology | 2018

von Ankerst, D. | Straubinger, J. | Selig, K. | +15

3

Complete metastasectomy for renal cell carcinoma : Comparison of five solid organ sites

enthalten in: Journal of surgical oncology | 2016

von Jakubowski, C. | Vertosick, E. | Untch, B. | +7

4

Global expression of AMACR transcripts predicts risk for prostate cancer - a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate

enthalten in: BMC urology | 2016

von Alinezhad, S. | Väänänen, R. | Ochoa, N. | +5

5

Comparison of perioperative outcomes of retroperitoneal and transperitoneal minimally invasive partial nephrectomy after adjusting for tumor complexity

enthalten in: Urology | 2014

von Gin, G. | Maschino, A. | Spaliviero, M. | +3

6

Relative value of race, family history and prostate specific antigen as indications for early initiation of prostate cancer screening

enthalten in: The Journal of urology | 2014

von Vertosick, E. | Poon, B. | Vickers, A.

CommentIn: J Urol. 2014 Sep;192(3):728; discussion 728-9. - PMID 24912065

1
[1]